A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

This study is testing a new drug called GNC-038 for people with non-Hodgkin's lymphoma — a type of blood cancer — whose disease has come back or stopped responding to prior treatments. GNC-038 is a bispecific antibody designed to help the immune system attack lymphoma cells. **You may be eligible if...** - You are between 18 and 75 years old - You have confirmed non-Hodgkin's lymphoma that has relapsed or is no longer responding to prior treatments - You have measurable lymphoma visible on imaging - Your cancer does not involve the brain or spinal cord - You are generally active and able to perform self-care **You may NOT be eligible if...** - You have active lung disease, interstitial lung disease, or a serious infection - You have active hepatitis B, hepatitis C, or HIV - You have had another cancer in the past 5 years - You have had a prior organ transplant or bone marrow transplant from a donor - You have had CAR-T therapy in the past 12 weeks - You have poorly controlled high blood pressure or a history of serious heart or stroke events - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.